Has anyone elected to receive triple drug therapy and delay their ASCT? Seems like there is increasing evidence that this may be a good approach.

The Evolving Role of Transplant in Multiple Myeloma in 2019 and Beyond - Dana-Farber Cancer Institute | Boston, MA

The use of autologous stem cell transplant (ASCT) for selected patients along with the introduction of novel agents has, over the past…

www.dana-farber.org